MENU
JSPR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Jasper Therapeutics (JSPR) Ownership - Who owns Jasper Therapeutics?

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy... Show more

Profile

Industry
N/A
Address
2200 Bridge Parkway
Phone
+1 650 549-1400
Employees
45
Web
https://www.jaspertherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
51.21M
P/E Ratio
N/A
Total Cash
50.9M
Projected Growth
N/A
Total Debt
1.7M
Revenue
N/A
Risk (Beta)
4.57
Dividend Yield
N/A
Total Cash/Share
1.82
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

JSPR
Capitalization
51.2M
P/E Ratio
N/A
Risk (Beta)
4.57
Dividend Yield
N/A
Total Cash
50.9M
Total Cash/Share
1.82
Total Debt
1.7M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
11.6M
P/B Ratio
4.43
Cash Flow
N/A
Earnings
-5.82
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
2.59
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-92.32M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-116.04
Shares Held By Institutions
50.8M
Shares Outstanding - Current
28M
Total Liabilities
45.9M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-91.441
View a ticker or compare two or three
JSPR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2200 Bridge Parkway
Phone
+1 650 549-1400
Employees
45
Web
https://www.jaspertherapeutics.com